James Clemens, MD
Urology · Ann Arbor, MINPI 1366405359
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $53,926 of the $62,737 with a category attached, or 86.0%. 15 manufacturers reported payments, led by GSK at 43.8% of the total. Among urology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $603.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$27K
- Urocure LLC$10K
- Purdue Pharma L.p.$7K
- AbbVie$5K
- Medtronic$3K
- Boston Scientific$3K
- plus $7K from 9 others
Across 7 payments — averaging $4347.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ironwood Pharmaceuticals, Inc$30K
- Coloplast$250
What the payments were for
- Consulting fees$53,92686%
- Speaking & faculty fees$1,6253%
- Travel & lodging$3,8476%
- Food & beverage$3,3405%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 13 | $27,490 |
| Urocure LLC | 9 | $9,768 |
| Purdue Pharma L.p. | 1 | $6,600 |
| AbbVie(2 entities) | 10 | $5,127 |
| Medtronic(2 entities) | 38 | $3,487 |
| Boston Scientific | 11 | $3,253 |
| Coloplast | 9 | $1,810 |
| Provepharm Inc. | 1 | $1,600 |
| H. Lundbeck A S | 1 | $1,500 |
| Astellas Pharma Global Development | 1 | $1,050 |
| Procept Biorobotics Corporation | 6 | $722 |
| Axonics, Inc. | 1 | $149 |
| Sumitomo Pharma America, Inc. | 1 | $125 |
| Urovant Sciences Inc | 1 | $38 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$62,737 in reported general payments places this provider in the 95th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 147 | $130,001 |
| Mirabegron ErMirabegron | 32 | $21,768 |
| GemtesaVibegron | 12 | $17,365 |
| Trospium Chloride ErTrospium Chloride | 50 | $10,159 |
| Methenamine Hippurate | 39 | $4,644 |
| Estradiol | 21 | $1,472 |
| Gentamicin Sulfate | 19 | $1,119 |
| Oxybutynin Chloride ErOxybutynin Chloride | 35 | $1,117 |
| Tamsulosin Hcl | 64 | $1,091 |
| Pregabalin | 12 | $437 |
| Finasteride | 17 | $369 |
| Solifenacin Succinate | 11 | $325 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $116 |
| Amitriptyline Hcl | 11 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $125 | $17,36512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 400 urology providers in Michigan.
Other urology in Ann Arbor
- William RobertsAnn Arbor$973K
- Khurshid GhaniAnn Arbor$413K
- Casey DauwAnn Arbor$188K
- Bahaa MalaebAnn Arbor$98K
- Todd MorganAnn Arbor$34K
- Stephanie KielbAnn Arbor$26K
- Yooni BlairAnn Arbor$22K
- John StoffelAnn Arbor$17K
- Lindsey HerrelAnn Arbor$15K
- Ashok ReddySterling Heights$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.